Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Neurology. 2003 Sep 9;61(5):704-6.

Psychiatric adverse events during levetiracetam therapy.

Author information

  • 1Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, UK.


The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three (10.1%) patients developed PAE. A significant association was found with previous psychiatric history, history of febrile convulsions, and history of status epilepticus, whereas lamotrigine co-therapy had a protective effect. PAE were not related to the titration schedule of LEV, and certain patients seem to be biologically more vulnerable.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk